by Combat Cancer | Jan 25, 2025 | News
Bladder cancer continues to be a pressing medical challenge, with different forms requiring different treatment approaches. While at Combat we primarily focus on non-muscle-invasive bladder cancer (NMIBC), recent advancements in diagnosing and treating the more...
by Combat Cancer | Jan 18, 2025 | News
Pancreatic cancer remains the world’s third deadliest form of cancer, behind lung and colorectal cancer. What makes pancreatic cancer so dangerous is largely due to its extremely aggressive nature and difficulties in early diagnosis. Among its various types,...
by Combat Cancer | Jan 10, 2025 | News
Non-Muscle-Invasive Bladder Cancer (NMIBC) is one of the most common forms of cancer worldwide, with around 2.5 times more men being affected than women. Age is another risk factor, with 56% of new cases being diagnosed in those aged 75 and over. However, treatments...
by Combat Cancer | Dec 20, 2024 | News
Bowel cancer is one of the most common forms of cancer worldwide, and has long been linked to the growth of polyps in the colon. Early intervention to inhibit these polyps holds the potential to drastically reduce cancer incidence. Excitingly, the ongoing phase 2/3...
by Combat Cancer | Dec 14, 2024 | News
Colorectal cancer is the second leading cause of cancer-related deaths worldwide, and has long been a focus of medical research. A groundbreaking new study published on 10th December in Gut, a leading international journal in gastroenterology and hepatology, has...
by Combat Cancer | Dec 6, 2024 | News
Bowel (colorectal) cancer is the third most common cancer worldwide, and the second biggest cause of cancer-related deaths. Despite this, it can be treated successfully if caught early. The annual “Decembeard” campaign was started by Bowel Cancer UK. This...
Recent Comments